Category: FEMTECH - Page 4 - Start Medical Product Development

Smart jumpsuit produces growth charts of infants’ motor performance

September 8, 2026

Researchers at the University of Helsinki and HUS Helsinki University Hospital have built normative growth charts for infants’ gross motor development using measurements made in the children’s own homes. In the study, 92 typically developing infants ages 4–19 months wore the MAIJU smart jumpsuit during free play, producing 580 measurements and 1,227 hours of data covering activities from lying on the floor to walking fluently.

HR HealthCare Launches Liv™ Pre-lubricated Intermittent Catheter for Women

September 3, 2026

YORK, Pa., Sept. 3, 2026 /PRNewswire/ — HR HealthCare today announced the introduction of the Liv™ Pre-lubricated Intermittent Catheter, developed to support women’s bladder management needs. For many women, intermittent self-catheterization is part of daily life alongside work, family, travel, and social commitments. Liv combines protective features with a modern profile and packaging designed to fit into busy lives.

Vara nets first CE mark for autonomous AI breast cancer screening tool

September 2, 2026

The autonomous triage system’s European market authorisation comes as AI becomes increasingly embedded into the cancer screening paradigm.

CergenX achieves CE Mark for pioneering AI technology designed to transform newborn brain assessment

September 1, 2026

Irish medtech company reaches major regulatory milestone for AI-powered technology providing rapid, objective insights into newborn brain activity

A ‘one-two punch’ against aggressive breast cancer could offer an alternative to chemotherapy

August 31, 2026

Triple-negative breast cancer (TNBC) has a frustrating ability to adapt. Although this aggressive form of breast cancer can initially respond well to chemotherapy, cancer cells often find ways to survive, allowing the disease to return and become resistant to treatment.

Scientists identify molecule driving one of the deadliest forms of breast cancer

August 21, 2026

Australian researchers have uncovered a promising new way to tackle one of the most aggressive forms of breast cancer, raising hopes for more effective treatments to stop the disease from spreading.

Single gene injection reverses inherited heart disease in mice and patient-grown tissue

August 19, 2026

Melbourne researchers have made a gene therapy breakthrough that could restore heart function in children with genetic heart disease, sparing them the need for transplants.

Human multi-organ chip tracks breast cancer spread to bone and lung

August 19, 2026

Cancer spreading beyond the primary tumor—a process known as metastasis—is responsible for at least two-thirds of cancer deaths. Drugs targeting metastatic progression have largely failed, in part because of the lack of predictive models that would help identify the underlying mechanisms of metastasis.

Livi®, the First FDA-Cleared After-Sex Absorption Device, Is Now Available

August 19, 2026

Doctor-created Livi addresses a long-overlooked need in post-sex intimate health, available exclusively at MyLivi.com.

Placental transport mechanism could guide safer biologic medicines during pregnancy

August 14, 2026

Biologic medicines have transformed the treatment of cancer, autoimmune diseases, migraine, inflammatory disorders and many other conditions. Yet their growing use among women of reproductive age constitutes a major clinical challenge because therapeutic IgG antibodies are actively transported across the placenta to the developing fetus. Evidence supporting the safe use of such therapeutics during pregnancy remains limited.